Homology modeling and calculation of the cobalt cluster charges of the Encephazlitozoon cuniculi methionine aminopeptidase, a potential target for drug design

Biophysical Chemistry

Volumn 105, Issue 1, 2003, Pages 29-43

  Bontems, François ^a,b   Le Floch, Pascal ^c   Duffieux, Francis ^a,b   Biderre, Corinne ^d,e   Peyret, Pierre ^d   Lallemand, Jean Yves ^a,b  

^a ECOLE POLYTECHNIQUE   (France)

^b INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

^c LABORATOIRE HÉTÉROÉLÉMENTS ET COORDINATION   (France)

^d UNIVERSITÉ CLERMONT AUVERGNE   (France)

^e Biogemma   (France)

Author keywords

AIDS; Fumagillin; Metallo enzyme; Microsporidium; Parasite

Indexed keywords

COBALT; FUMAGILLIN; FUMAGILLOL CHLOROACETYLCARBAMATE; METHIONYL AMINOPEPTIDASE;

AB INITIO CALCULATION; ARTICLE; BINDING AFFINITY; DRUG ACTIVITY; DRUG DESIGN; DRUG TARGETING; ENCEPHALITOZOON CUNICULI; ENZYME ACTIVE SITE; MOLECULAR INTERACTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

ENCEPHALITOZOON CUNICULI; ENTEROCYTOZOON; MICROSPORIDIUM;

EID: 0042160088     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-4622(03)00056-5     Document Type: Article

References (27)

1. Canning E.U., Lom J. The Microsporidia of Vertebrates. 1986;Academic Press Inc, New York, NY.
2. Kotler D.P., Orenstein J.M. Clinical syndromes associated with microsporidiosis. Adv. Parasitol. 40:1998;1-49.
3. Raynaud L., Delbac F., Broussolle V., Rabodonirina M., Girault V., Wallon M., et al. Identification of E. intestinalis in travelers with chronic diarrhea by specific PCR amplification. J. Clin. Microbiol. 36:1998;37-40.
4. Cotte L., Rabodonirina M., Chapuis F., Bailly F., Bissuel F., Raynal C., et al. Waterborne outbreak of intestinal microsporidiosis in persons with and without human immunodeficiency virus infection. J. Infect. Dis. 180:1999;2003-2008.
5. van Gool T., Vetter J.C., Weinmayr B., Van Dam A., Derouin F., Dankert J. High seroprevalence of Encephalitozoon species in immunocompetent subjects. J. Infect. Dis. 175:1997;1020-1024.
6. Aarons E.D., Woodrow W.S., Hollister E.U., Canning E.U., Francis N., Gazzard B.G. Reversible renal failure caused by a microsporidian infection. AIDS. 8:1994;1119-1121.
7. Shadduck J.A. Effect of fumagillin on in vitro multiplication of E. cuniculi. J. Protozool. 27:1980;202-208.
8. Weber R., Sauer B., Spycher M.A., Deplazes P., Keller R., Ammann R., et al. Detection of Septata intestinalis in stool specimens and coprodiagnostic monitoring of successful treatment with albendazole. Clin. Infect. Dis. 19:1994;342-345.
9. Weber R., Deplazes P., Flepp M., Mathis A., Baumann R., Sauer B., et al. Cerebral microsporidiosis due to E. cuniculi in a patient with human immunodeficiency virus infection. N Engl. J. Med. 336:1997;474-478.
10. Kruger E.A., Figg D.W. TNP-470: an angiogenesis inhibitor in clinical development for cancer. Exp. Opin. Invest. Drugs. 9:2000;1383-1396.
11. Sin N., Meng L., Wang M.Q., Wen J.J., Bornmann W.G., Crews C.M. The anti-angiogenic agent fumagillin covalently binds and inhibits ths methionine aminopeptidase MetAP-2. Proc. Natl. Acad. Sci. USA. 12:1997;6099-6103.
12. Katinka M.D., Duprat S., Cornillot E., Metenier G., Thomarat F., Prensier G., et al. Genome sequence and gene compaction of the eukaryote parasite E. cuniculi. Nature. 414:2001;450-453.
13. Li R., Chen X., Gong B., Selzer P.M., Li Z., Davidson E., et al. Structure-based design of parasitic protease inhibitors. Bioorg. Med. Chem. 4:1996;1421-1427.
14. Byington C.L., Dunbrack R.L., Whitby F.G., Cohen F.E., Agabian N. Entamoeba histolytica: computer-assisted modeling of phosphofructokinase for the prediction of broad-spectrum antiparasitic agents. Exp. Parasitol. 87:1997;194-202.
15. Liu S., Widom J., Kemp C.W., Crews C.M., Clardy J. Structure of human methionine aminopeptidase-2 complexed with fumagillin. Science. 282:1998;1324-1326.
16. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234:1993;779-815.
17. Laskowsky R.A., Rullmann J.A.C., MacArthur M.W., Kaptein R., Thronton J.M. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR. 8:1996;477-486.
18. Brünger A.T. X-PLOR Version 3.1, a System for X-ray Crystallography and NMR. 1992;Yale University Press, New Haven and London.
19. Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., et al. GAUSSIAN 98, Revision A.9. 1998;Gaussian Inc, Pittsburgh, PA, USA.
20. Koradi R., Billeter M., Wüthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graphics. 14:1996;51-55.
21. Lowther W.T., Zhang Y., Sampson P.B., Honek J.F., Matthews B.W. Insights into the mechanism of the E. coli methionine aminopeptidase from the structural analysis of the reaction products and phosphorus-based transition state analogues. Biochemistry. 38:1999;14810-14819.
22. Tahirov T.H., Oki H., Tsukihara T., Ogashara K., Yutani K., Ogata K., et al. Crystal structure of the methionine amminopeptidase from hyperthermophile P. furiosus. J. Mol. Biol. 284:1998;101-124.
23. Becke A.D. Density-functional exchange-energy approximation with correct asymptotic behavior. Phys. Rev. 38:1988;3098.
24. Hay P.J., Wadt W.R. Ab-initio effective core potential for molecular calculation. Potential for K to Au including the outermost core orbital. J. Chem. Phys. 82:1985;299-310.
25. Reed A.E., Curtis L.A., Weinhold F. Intermolecular interactions from a natural bond orbital, donor-acceptor viewpoint. Chem. Rev. 88:1988;899-926.
26. Roderick S.L., Matthews B.W. Structure of the cobalt-dependent methionine aminopeptidase from E. coli: a new type of proteolytic enzyme. Biochemistry. 32:1993;3907-3912.
27. Lowther W.T., Matthews B.W. Structure and function of the methionine aminopeptidase. Biochem. Biophys. Acta. 1477:2000;157-167.